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Edited by Christian GriesingerAbstract The YukD protein in Bacillus subtilis was identiﬁed in
a hidden Markov model (HMM) search as being related in se-
quence to ubiquitin. By solving the crystal structure we show that
YukD adopts a fold that is most closely related to ubiquitin, yet
has the shortest C-terminal tail of all known ubiquitin-like pro-
teins. The endogenous gene of yukD in B. subtilis was disrupted
without an obvious phenotypic eﬀect and an inducible copy
encoding a C-Myc and His-tagged version of the protein was
introduced at the ectopic locus amyE. Conjugation assays per-
formed both in vitro and in vivo indicate that YukD lacks the
capacity for covalent bond formation with other proteins.
 2005 Published by Elsevier B.V. on behalf of the Federation of
European Biochemical Societies.
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Ubiquitin is an abundant and conserved protein in eukary-
otes that covalently binds to proteins, ﬂagging them for pro-
tein degradation by the proteasome or for post-translational
modiﬁcation [1,2]. Once processed, ubiquitins C-terminal gly-
cine binds covalently to its target substrate through an isopep-
tide bond, formed between the C-terminus and the e-amino
groups of a lysine residue in the acceptor protein. Ubiquitina-
tion requires ATP and a cascade of enzymes (E1, E2, and E3).
Despite being ubiquitous in eukaryotes, no ubiquitin-like pro-
tein has been found in bacteria that signals proteins for degra-
dation. It is still a mystery how in bacteria selective protein
breakdown is regulated and mediated by the energy-dependent
proteases Lon, FtsH, HSLUV and the ClpA/XP complexes
[1,3]. The half-life of a protein in bacteria is dependent on its
N-terminal amino acid sequence (N-end rule), which is recog-
nized by the ClpA/XP complex [4]. Small eﬀecter molecules
regulate protein degradation, e.g. TraR [5], and also the asso-
ciation or dissociation of other proteins can control degrada-
tion of their binding partner (reviewed in [3]). Sometimes
rapid, constitutive degradation combined with regulated gene
expression directs protein levels, e.g. the SOS response protein
SulA, which is degraded by LON protease [6]. In bacteria only
one example is known where a covalently bound peptide tag
targets proteins for degradation. The 11 amino acid co-trans-
lational SsrA-tag functions as a signal for degradation of pro-
teins that are arrested in translation and form a substrate for
ClpXP complex [7].
So far, the only known single-domain ubiquitin-like proteins
in bacteria are the protein-based sulphur donor systems ThiS-*Corresponding author. Fax: +44 1223 213556.
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minal double glycine motif as ubiquitin, which, upon activa-
tion, becomes covalently attached to a cysteine on their
activating enzymes ThiF and MoeB, respectively. Following
this, a sulphur transferase step results in the formation of a
thio-carboxylate, which acts as the sulphur donor in either thi-
amin synthesis or Molybdenon Cofactor biosynthesis.
Although the functions of these proteins is diﬀerent from that
of ubiquitin, the sulphur transferase mechanism as well as their
structural similarity points towards an evolutionary link
between these proteins and ubiquitin [8–10].
Eukaryotes have single-domain ubiquitin-like (UBL) pro-
teins (e.g. SUMO-1, RUB-1, NEDD8) that conjugate to other
proteins using a similar chemistry as the sulphur donor-system
described above, but rather than being involved in protein deg-
radation, they are part of a wide variety of speciﬁc biological
processes [11]. Most UBL proteins require an extra maturation
step through C-terminal hydrolysis that makes the double gly-
cine motif available for conjugation. The yeast UBL protein
Hub1 lacks the C-terminal glycine motif usually used for con-
jugation to proteins and initial evidence suggested that Hub1
protein linkage might occur via a conserved tyrosine at the
penultimate position of Hub1 [12]. Recent results, however,
indicate that the detected protein interactions are of a non-
covalent nature and furthermore the C-terminus of Hub1 is
dispensable for its function [13].
In the past, several groups have searched for ubiquitin-like
proteins in bacteria. Biochemical experiments were performed
on protein extracts from the halobacterium Natronococcus
occultus as well as the cyanobacterium Anabaena variabilis that
showed cross-reactivity with antibodies raised against ubiqui-
tin [14,15]. However, the identity of these proteins remained
elusive. In a computational approach, sequence data were
combined with structural information and three single-domain
ubiquitin-like proteins were predicted to exist in Archaea [16].
No biochemical data are available that show ubiquitin-like
conjugation of any form for these proteins.
The YukD protein in Bacillus subtilis was not identiﬁed as a
potential candidate in the study mentioned above, but was
found using a hidden Markov model (HMM) search with
ubiquitin. YukD is not very widely conserved and its function
is unknown. It is part of a large operon that constitutes the
genes yukABCDE [17,18]. By solving the crystal structure we
show that YukD adopts a fold that is most closely related to
ubiquitin, yet has the shortest C-terminal tail of all known
UBL proteins. The endogenous gene of yukD in B. subtilis
was disrupted and an inducible copy encoding a C-Myc and
His-tagged version of the protein was introduced at the ectopic
locus amyE. Conjugation assays were performed both in vitro
and in vivo.ation of European Biochemical Societies.
Table 2
Reﬁnement statistics
NATI
Residues 1–79
Resolution 2.7 A˚
R-factor, R-freea 0.241, 0.296
B averageb 53.3 A˚2
Geometry bonds/anglesc 0.009 A˚, 1.144
Ramachandrand 78%/0.0%
PDB IDe 2 bps
a5% of reﬂections were randomly selected for determination of the free
R-factor, prior to any reﬁnement.
bTemperature factors averaged for all atoms.
cRMS deviations from ideal geometry for bond lengths and restraint
angles [31].
dPercentage of residues in the most favoured region of the Rama-
chandran plot and percentage of outliers (PROCHECK [32]).
eProtein Data Bank identiﬁers for coordinates and structure factors,
respectively.
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2.1. Bacterial expression and protein puriﬁcation
All B. subtilis strains were grown in antibiotic medium No. 3 (Oxoid)
supplemented with the required antibiotics.
The gene for the 79-amino acid protein YukD (Accession number
BG12377; TrEMBL P71071) was ampliﬁed from B. subtilis genomic
DNA (ATCC 23857D) by PCR. The N-terminus of YukD is preceded
by HHHHHHGS, encoded by the forward primer (5 0 AGTCTACCA-
TATGCATCACCATCACCATCACGGAAGCTATATTGATAT-
TACAATAGATTTG). No extra residues were amended to the
C-terminus (reverse primer: TGACTACGGATCCTCATAATATTT-
CAAGCCGGTCTCCGTT). The PCR product was cleaved with Bam-
HI/NdeI and ligated into BamHI/NdeI digested pHis17 (B. Miroux,
personal communication), generating pHisBSD. In a similar way, a
ﬂag-tagged version of the protein was made by introducing the ﬂag-
tag sequence with the forward primer (5 0 AGTCTACCATATGGAC-
TACAAGGACGACGATGACAAGGGAAGCTATATTGATATT-
ACAATAGATTTG). His-tagged protein was expressed in C41 cells
[19] and puriﬁed using Ni2+-NTA aﬃnity puriﬁcation at pH7.0, essen-
tially as described [20]. After the protein was eluted from the column,
the buﬀer was exchanged on a G25 column into TEN8.0 (20 mM Tris,
8.0, 1 mM EDTA, 1 mM Na-azide) supplemented with 2 mM DTT.
The protein was then concentrated by ultraﬁltration before loading
onto a size-exclusion column Sephacryl S100 in TEN8.0, in the pres-
ence of 2 mM DTT. Selenomethionine-containing YukD was ex-
pressed as described previously [20] and was puriﬁed as the native
protein with the addition of 5 mM b-mercaptoethanol for the Ni2+-
NTA aﬃnity puriﬁcation and 5 mM DTT for all other puriﬁcation
steps. Flag-tagged YukD was overexpressed in C41 cells [19], aﬃnity
puriﬁed using the ﬂag-tag, according to the manufacturers protocol
(Sigma) and further puriﬁed over a superdex75 column in 50 mM
Tris7.4 and 150 mM NaCl.
2.2. Crystallisation and structure determination
YukD was crystallised at 10 mg/ml by sitting-drop vapour diﬀusion
in 100 mM citrate 5.5, 1 M ammonium sulphate and the crystals were
ﬂash frozen in liquid nitrogen with mother liquor containing 22% glyc-
erol. Selenomethionine substituted YukD crystallised in 0.1 M MES
6.3, 0.45 M Na/K tartrate and the crystals were frozen in mother liquor
containing 4.8 M LiCl. Heavy metal derivatives were obtained by
soaking the native crystals in 0.3–4 mM EMTS, PbAc, or PclHgben-
zene overnight. YukD crystals belong to spacegroup P41212 with
two molecules in the asymetric unit. Cell constants were a = 50.32 A˚,
b = 50.32 A˚, c = 174.93 A˚ (Table 1). Datasets were collected at beam-
lines SRS 14.2 (native dataset) and ESRF ID29 (selenomethionine
containing crystals and derivatives).
All data were indexed and integrated with MOSFLM [21] and fur-
ther processed using the CCP4 package [22]. An initial electron density
map was generated by combining the MAD data and the lead and mer-
cury data using SOLVE [23] and phases were calculated with SHARP
[24]. The model was built manually with the program MAIN [25]
and reﬁned using CNS [26]. Details of the reﬁned model are shown
in Table 2.Table 1
Crystallographic data (P41212: a = 50.32 A˚, b = 50.32 A˚, c = 174.93 A˚)
Crystal k (A˚) Resolution (A˚) I/rIa Rm
b Multiplicityc
EMTS 0.9202 2.9 11.0(3.2) 0.131 6.5
PClHgb 0.9202 2.7 10.0(3.3) 0.109 4.6
PbAc 0.9202 2.8 9.8(3.3) 0.099 4.6
PEAK 0.9791 3.2 12.8(6.1) 0.096 5.7
INFL 0.9793 3.2 15.4(7.3) 0.099 7.3
HREM 0.9762 3.2 14.1(7.4) 0.104 7.6
NATI 0.9700 2.7 12.2(2.7) 0.076 4.4
aSignal to noise ratio of intensities, highest resolution bin in brackets.
bRm:
P
h
P
ijI(h,i)  I(h)j/
P
h
P
i I(h,i) where I(h,i) are symmetry related
intensities and I(h) is the mean intensity of the reﬂection with unique
index h.
cMultiplicity for unique reﬂections, for MAD datasets I(+) and I()
are kept separate.2.3. Disruption of yukD and complementation by an inducible allele
The B. subtilis yukD gene was ampliﬁed using KOD hotstart DNA
polymerase (Novagen) from pHisBSD with a forward primer including
an Xba site, a RBS, an ATG and an SpeI site (5 0-AGTCTACTCTA-
GAAAGGAGATTCCTAGGATGACTAGTCATCACCATCAC-
CATCACGGAAGC) and a reverse primer, including a stop codon
and a NotI site (5 0-TGACTACGCGGCCGCTCATAATATTT-
CAAGCCGGTCTCCGTT). The PCR product was digested with
XbaI and NotI and ligated to the corresponding sites of pJPRI vector
(J. Rawlins, J. Errington, pers. Communication), generating pFE188.
pJPRI carries the 5 0 and 3 0 portions of the amy gene of B. subtilis ﬂank-
ing a neomycin resistance gene upstream of a xylose-inducible pro-
moter (Pxyl). Plasmid 3390 (gift from K. Nasmyths lab, IMP,
Vienna) encoding 9 copies of the C-myc epitope between SpeI sites
was digested with SpeI and the isolated c-myc region was ligated into
SpeI-digested PFE188, generating pFE189. PFE189 was transformed
into B. subtilis strain 168ED with selection for choramphenicol
(5 lg/ml) resulting in strain BS189 (bla amyE::cat Pxyl-c-myc-his-
yukD). Clones having an insertion in the amy locus were selected based
on their inability to convert starch on a starch/chloramphenicol con-
taining plate.
Subsequently, the wild type copy of the yukD gene was disrupted by
inserting a neo cassette into the gene. A PCR product of 2 Kb of the
upstream DNA sequence of YukD followed by 78 basepairs of the
5 0 end of the gene was cloned into SphI/PstI-digested vector derived
from pBEST501 [27], generating pFE138. In the same way, 2 Kb of
the downstream sequence of yukD preceded by 140 basepairs of the
3 0 end of yukD was ampliﬁed and cloned into NotI/BamHI-digested
vector derived from pFE138, resulting in plasmid pFE139. PFE139
was transformed into BS189 and transformants were grown on plates
containing 0.5% xylose and 5 lg/ml kanamycin, generating strain
BS139. All strains were PCR checked on genomic DNA and clones
were veriﬁed by DNA sequencing.
2.4. Conjugation assay
In vitro reaction. Puriﬁed ﬂag-tagged YukD (40 ng) was incubated
in the presence of either 10 mM Mg-ATP or 12.5 mM EDTA, with
or without B. subtilis extract (see legends to Fig. 4). For the latter, a
50 ml culture of wild type B. subtilis was grown until OD600 = 0.5.
The cells were lysed using 0.7 ml Y-PER (Pierce) and incubated for
20 min at RT, after which the extract was cleared by spinning at 13k
for 10 min, at 4 C. Reactions were performed at 37 C for 20 min
and were terminated by adding an equal volume of loading dye and
heating for 5 min at 99 C.
In vivo reaction. B. subtilis strains 168ED, BS138 and BS139 were
grown in antibiotic medium No. 3 (Oxoid) supplemented with 5 lg/
ml chloramphenicol (BS138) and 5 lg/ml kanamycin, 1% xylose
(BS139) until late log-phase. Cells from 500 ml culture were lysed in
10 ml lysis buﬀer (8 M urea, 50 mM Tris 8.0, 20 mM imidazole) with
two passes through a French press followed by 1 min sonication. Cell
debris was removed by centrifugation and the supernatant puriﬁed
over a Ni2+-NTA spin column. The columns were washed extensively
Fig. 1. Stereo view of a ribbon plot of the crystal structure of YukD.
The secondary structure elements are labelled in sequential order (S for
strand and H for helix), changing colours from the N-terminus (blue)
to the C-terminus (red). The ﬁgure was made with Pymol [30].
Fig. 2. Single-domain ubiquitin-like proteins with structures most similar
Ubiquitin is 1ubi, for Hub1 is 1m94, SUMO-1 is 1A5R, MOAD is 1fm0,
Ubiquitin is 14% (including Lys48), between YukD and Hub1 is 8%, between
depicted in rainbow colours, with the N-terminus in blue and the C-terminu
F. van den Ent, J. Lo¨we / FEBS Letters 579 (2005) 3837–3841 3839and the protein was eluted in lysis buﬀer supplemented with 600 mM
imidazole. The eluent was precipitated with TCA, heated for 5 min
at 99 C in 50 mM DTT. The samples were analysed on a 12.5%
SDS–PAGE gel (Biorad) and immunoblotted using a monoclonal anti-
body against the C-myc epitope (9E10, Sigma).3. Results and discussion
The structure of YukD shows the typical b-grasp fold of
ubiquitin with two N-terminal anti-parallel b-strands con-
nected to a a-helix, followed by a third b-strand that is linked
via a helical turn to a fourth b-strand, which runs into a ﬁfth b-
strand via another helical turn (Fig. 1). The b-strands are ar-
ranged in the order S4pS3aS5pS1pS2a.
Structural comparison reveals that YukD and ubiquitin
have the strongest resemblance among the single-domain ubiq-
uitin-like proteins in the protein database, with an RMSD of
2.2 A˚ (Fig. 2) (using the DALI-web server [28]). However, a
striking diﬀerence becomes apparent from a structure-basedto YukD (using DALI output EBI, Hinxton, [28]). PDB entry for
ThiS is 1F0Z. Structure-based sequence identity between YukD and
YukD and ThiS/Moad is 8% and 9%, respectively. Each ribbon plot is
s in red. The ﬁgure was made using Pymol [30].
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ends before the double glycine motif in ubiquitin (Fig. 3). The
yeast protein Hub1 (with an RMSD of 2.5 A˚) also has a much
shorter C-terminal tail compared to ubiquitin (Figs. 2 and 3).
Despite the absence of the double glycine motif at the C-termi-
nus of Hub1, initial experiments suggested that Hub1 might
conjugate with the conserved penultimate tyrosine [12]. How-
ever, recent evidence contradicted these ﬁndings, revealing that
the conserved tyrosine residue is not required for formation of
higher molecular weight complexes with Hub1 [13]. Precisely
how Hub1 forms these SDS-resistant complexes is not clear
at present. Small-ubiquitin-like modiﬁer (SUMO-1) does con-
jugate to other proteins, although its role is to stabilize rather
than to degrade proteins [29]. The Rmsd of SUMO-1 relative
to YukD is 2.7. Bacterial proteins MoaD and ThiS have an
RMSD of 2.6 and 2.9 compared to YukD (Fig. 2). Both
MoaD and ThiS have the double glycine at their C-terminal
tails (Fig. 3), with which they are conjugated to their activating
enzymes. In contrast to ubiquitin, a sulphur transferase step
converts the conjugated product into a thio-carboxylate, which
acts as sulphur donor in thiamin and Molybedenon Cofactor
biosynthesis.
The striking structural similarity between YukD and ubiqui-
tin prompted us to examine whether YukD would be able to
conjugate to other proteins. Aﬃnity puriﬁcation and immu-
noblot analysis were combined to investigate whether any
complexes were made either in vitro or in vivo. Puriﬁed ﬂag-
tagged YukD was incubated with extracts from B. subtilis in
the presence or absence of Mg-ATP and reactions were ana-Fig. 3. Structure-based sequence alignment of the 15 C-terminal
residues of YukD with Ubiquitin, SUMO1, Hub1, ThiS and MoaD
proteins, shows that the C-terminal tail of YukD is the shortest of
them all.lysed by SDS–PAGE and immunoblot (Fig. 4A). Clearly,
ﬂag-tagged YukD does not form higher molecular weight com-
plexes under these conditions. To rule out the possibility of
competition with endogenous YukD, the wildtype copy of
yukD was disrupted by introducing a neo-cassette into the gene
and a tagged version of YukD was expressed under the control
of the Pxyl promoter at an ectopic locus (amyE) in B. subtilis
(strain BS139; see Section 2). Since YukD was N-terminally
tagged with C-Myc and 6 histidines, any putative complexes
made by YukD in vivo should elute from a Ni2+-NTA column,
which could then be detected by immunoblot analysis using an
anti-C-Myc antibody. The resultant strain BS139 was viable,
even after extensive growth in the absence of xylose, indicating
that YukD is not essential. This is consistent with a recent
study describing the knockout of yueE and surrounding genes,
including yukD [17]. Extracts from BS139 grown in the pres-
ence of 1% xylose were puriﬁed and analysed by immunoblot-
ting (Fig. 4B). Even by increasing the sensitivity of the assay
using 9 copies of the epitope C-Myc fused to YukD, only
two very weak bands were visible on an overloaded gel. The
nature of these bands are presently unclear, but are most likely
not the result of conjugation, since they partially disappear
after heating the sample in 50 mM DTT (compare lanes 4
and 5 in Fig. 4B). The band indicated by a single star is possi-
bly a dimer of tagged YukD (Fig. 4B). The most likely expla-
nation for the absence of a covalent interaction is the short
C-terminal tail that lacks the double glycine motif, essential
for conjugation of all known UBL proteins. Apparently, the
ubiquitin-like fold of YukD is required for a diﬀerent function
for which the extended C-terminal tail is not necessary.Fig. 4. Conjugation assay with YukD. (A) Puriﬁed N-terminally ﬂag-
tagged YukD was incubated with ATP (lane 2), with EDTA (lane 3),
and by itself (lane 4). Extract from B. subtilis was incubated without
addition of YukD (lane 5), with YukD and ATP (lane 6) and with
YukD and EDTA (lane 7). Lane 1 contains the marker proteins of 120,
100, 80, 60, 50, 40, 30 and 20 kDa. The reactions were separated on a
4–20% gradient gel and immunoblotted using an anti-ﬂag antibody.
(B) Extracts from B. subtilis strains BS138 (YukD knock-in to the
amyE locus, lane 2), 168ED (WT, lane 3) and BS139 (YukD knock-out
and knock-in, lane 4–6) were aﬃnity puriﬁed and analysed on a 12.5%
SDS–PAGE gel followed by immunoblotting with anti-C-Myc anti-
body. The samples mixed with 50 mM DTT containing loading dye
and were either heated for 5 min at 99 C (lanes marked a), or directly
loaded (lane b). Lane 6 (marked c) contains diluted cells of strain
BS139. The marker lane 1 has proteins 120, 100, 80, 60, 50, 40, 30 and
20 kDa.
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